Brand Name

Soaanz

Generic Name
Torsemide
View Brand Information
FDA approval date: June 01, 2004
Classification: Loop Diuretic
Form: Tablet

What is Soaanz (Torsemide)?

SOAANZ is indicated in adults for the treatment of edema associated with heart failure or renal disease. SOAANZ is a loop diuretic indicated in adults for the treatment of edema associated with heart failure or renal disease.
Save this treatment for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms

Related Clinical Trials

Bumetanide vs. Furosemide for Adults Hospitalized With Cirrhosis: the BUFF Trial

Summary: Patients with cirrhosis are frequently hospitalized due to an acute decompensation of their liver disease including bleeding, jaundice, encephalopathy, and volume overload. Volume overload is associated with increased mortality from acute hypoxic respiratory failure, hemorrhage from esophageal varices, and spontaneous bacterial peritonitis. Clinical practice guidelines describe sodium restriction ...

A Comparative Bioavailability of Two Torasemide 10 mg Tablets Formulations in Healthy Adult Participants Under Fasting Conditions: a Prospective, Open-label, Randomized, Single-dose, Two-treatment, Two-period, Two-sequence, Crossover Bioequivalence Study

Summary: The purpose of this study is to evaluate the bioavailability, safety and tolerability of Torasemide 10 mg tablets (Berlin-Chemie AG), compared to Unat® 10 tablets (Viatris Healthcare GmbH) in healthy adult participants under fasting conditions.